Insider · CIK 0001722673
Adam D. Cutler
Files at MURA (Mural Oncology plc). First filing Nov 1, 2024, latest Nov 10, 2025.
In brief
Adam D. Cutler files SEC Form 4 as CFO at MURA (Mural Oncology plc). Since Nov 1, 2024, Adam D. Cutler has reported 0 open-market buys worth $0 and 2 open-market sells worth $40k, the latest filed on Nov 10, 2025.
A track record needs three past buys with six months of prices behind them; Adam D. Cutler has 0, so none is measured yet.
The newest scored trade: sold $15k of MURA on Nov 3, 2025, filed Nov 10, 2025, scored 10 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $15k.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | Mural Oncology plc | $15k 7,148 shares | -7% | - | |
| 15Weak | Mural Oncology plc | $25k 7,421 shares | -9% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 10, 2025 | MURA Mural Oncology plc | 7,148 0.04% of outstanding | $15k | Nov 3, 2025 | none |
| Nov 1, 2024 | MURA Mural Oncology plc | 7,421 0.04% of outstanding | $25k | Oct 31, 2024 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | MURA Mural Oncology plc | DDisposition to issuer Ordinary Shares | -99,290 | - | - | 0 | Dec 5, 2025 |
| Dec 5, 2025 | MURA Mural Oncology plc | DDisposition to issuer Stock Option (right to buy)derivative | -146,452 | - | - | 0 | Dec 5, 2025 |
| Dec 5, 2025 | MURA Mural Oncology plc | DDisposition to issuer Stock Option (right to buy)derivative | -65,000 | - | - | 0 | Dec 5, 2025 |
| Nov 3, 2025 | MURA Mural Oncology plc | SOpen-market sale Ordinary Shares10b5-1 | -7,148 | $2.09 | $15k | 99,290 | Nov 10, 2025 |
| Mar 3, 2025 | MURA Mural Oncology plc | AGrant or award Ordinary Shares | +35,000 | $0.00 | $0 | 106,438 | Mar 5, 2025 |
| Mar 3, 2025 | MURA Mural Oncology plc | AGrant or award Stock Option (right to buy)derivative | +65,000 | $0.00 | $0 | 65,000 | Mar 5, 2025 |
| Oct 31, 2024 | MURA Mural Oncology plc | SOpen-market sale Ordinary Shares10b5-1 | -7,421 | $3.41 | $25k | 71,438 | Nov 1, 2024 |
| Dec 14, 2023 | MURA Mural Oncology plc | AGrant or award Ordinary Shares | +78,859 | $0.00 | $0 | 78,859 | Dec 18, 2023 |
| Dec 14, 2023 | MURA Mural Oncology plc | AGrant or award Stock Option (right to buy)derivative | +146,452 | $0.00 | $0 | 146,452 | Dec 18, 2023 |
Questions about Adam D. Cutler
Answered from the filings on this page, as of the latest one.
Is Adam D. Cutler buying or selling?
In the last 12 months Adam D. Cutler reported 0 open-market buys worth $0 and 1 open-market sell worth $15k on SEC Form 4; the latest was sold $15k of MURA on Nov 3, 2025. Grants, option exercises and tax withholding are not counted.
How did Adam D. Cutler's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Adam D. Cutler has 0.
Where does Adam D. Cutler file Form 4?
Adam D. Cutler has filed Form 4 at MURA (Mural Oncology plc) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.